It is easy to remove the target band! It has a large surface area and strong hydrophobic interactions.
The "Fluorotrans PVDF membrane" achieves high sensitivity protein detection with low background and low protein leaching. It is suitable for various protein analysis applications, including sequencing and Western transfer. With a large surface area and strong hydrophobic interactions, it has a higher protein adsorption capacity than nylon or nitrocellulose transfer membranes. 【Features】 ■ Achieves high sensitivity protein detection with low background and low protein leaching ■ Large surface area with strong hydrophobic interactions ■ Higher protein adsorption capacity than nylon or nitrocellulose ■ Suitable for various protein analysis applications, including sequencing and Western transfer *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications】 ■Media: Hydrophobic Polyvinylidene Fluoride ■Pore Size: 0.2μm ■Chemical Compatibility Resistant to Acetone, DMSO, Dimethylformamide, Methanol, Trifluoroacetic Acid, and Triethylamine *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Fluorotrans W Membrane - Western blotting transfer ■ Fluorotrans PVDF Membrane - N-terminal protein sequencing *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
